Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2008 2
2009 5
2010 2
2011 2
2012 3
2013 3
2014 7
2015 2
2016 3
2017 3
2018 2
2019 1
2020 3
2021 7
2022 5
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Ocular Manifestations of Systemic Diseases.
Nowinska AK, Machalińska A, Módis L, Koprowski R, Rechichi M. Nowinska AK, et al. J Ophthalmol. 2018 Oct 24;2018:7851691. doi: 10.1155/2018/7851691. eCollection 2018. J Ophthalmol. 2018. PMID: 30647963 Free PMC article. No abstract available.
[Meibomian gland dysfunction--review].
Nowińska A, Wylegała E, Tarnawska D, Janiszewska D, Dobrowolskia D. Nowińska A, et al. Klin Oczna. 2012;114(2):147-52. Klin Oczna. 2012. PMID: 23346806 Review. Polish.
Image Processing in Ophthalmology.
Koprowski R, Nowińska A, Wilczynski S, Lanza M, Molebny V, Ambrosio R Jr. Koprowski R, et al. Among authors: nowinska a. J Healthc Eng. 2018 May 20;2018:1545632. doi: 10.1155/2018/1545632. eCollection 2018. J Healthc Eng. 2018. PMID: 29887981 Free PMC article. No abstract available.
TFOS Lifestyle Report: Impact of environmental conditions on the ocular surface.
Alves M, Asbell P, Dogru M, Giannaccare G, Grau A, Gregory D, Kim DH, Marini MC, Ngo W, Nowinska A, Saldanha IJ, Villani E, Wakamatsu TH, Yu M, Stapleton F. Alves M, et al. Among authors: nowinska a. Ocul Surf. 2023 Jul;29:1-52. doi: 10.1016/j.jtos.2023.04.007. Epub 2023 Apr 14. Ocul Surf. 2023. PMID: 37062427
Advanced Anterior Eye Segment Imaging for Ichthyosis.
Micińska A, Nowińska A, Teper S, Kokot-Lesik J, Wylęgała E. Micińska A, et al. Among authors: nowinska a. J Clin Med. 2023 Sep 16;12(18):6006. doi: 10.3390/jcm12186006. J Clin Med. 2023. PMID: 37762949 Free PMC article.
56 results